Casey Kristin Frye > News
Bristol-Myers Squibb announced the results of the Phase 3 clinical trial of the investigational compound dapaglifozin, which is used to treat blood sugar levels in... Read More »
Yesterday, Agilent Technologies announced a large sale of equipment to the Virginia Tech department of chemistry. The undergraduate laboratory of Virginia Tech will... Read More »
Yesterday, Northrop Grumman Corporation delivered its innovative flight software to NASA that will enable the James Webb Space Telescope to communicate with the... Read More »
Janssen Biotech announced today that it has negotiated an agreement with Pharmacyclics to develop and market PCI-32765, an anti-cancer compound. Janssen Biotech, a... Read More »
Yesterday, Samsung and Biogen announced that they have entered an agreement for the development, manufacturing, and marketing of biosimilars. Samsung Biologics was... Read More »
Merck announced today the establishment of a new Research and Development headquarters in Beijing, China, which is part of a $1.5 billion dollar investment push for... Read More »
After ten years of rigorous research, scientists at King's College London announced that they have submitted the first “xeno-free” human stem cells to ... Read More »
Amgen announced today that the FDA has agreed to modify the requirements of the Nplate® Risk Evaluation and Mitigation Strategy Program (REMS). When reviewing the ... Read More »
McKesson High Volume Solutions will introduce ExpressRx Track this week in New Orleans at the 46th American Society of Health-system Pharmacists Midyear Clinical... Read More »
Mylan announced today The FDA has granted final approval for its Abbreviated New Drug Application for Tranexamic Acid Injection. This generic version of Pharmacia... Read More »
Research indicates that small toxin protein assemblies that aggregate Alzheimer's disease may be treated with a red dye found in lichens. Traditionally, the dye... Read More »
Mylan confirmed today that they and Family Care have been sued by Warner Chilcott over a filed Abbreviated New Drug Application. The application was filed for... Read More »
Pfizer announced today that the acquisition of Ferrosan Consumer Health’s business has been completed. The acquisition includes a line of successful lifestyle... Read More »
The drug peddling gangsters and cartels of tomorrow may be more "nanotech kingpin" than "Pablo Escobar" according to an extensive study by a... Read More »
Janssen International NV, a subsidiary of Johnson & Johnson, announced yesterday that the European Commission approved the drug EDURANT® as a... Read More »
Brystol-Myers Squibb company and Pfizer inc announced the FDA has accepted a new drug application for the drug ELIQUIS®. The compound is intended for stroke and... Read More »
Agilent Technologies announced today that Budapest Technology University successfully conducted research after installing Agilent's SuperNova diffractometer ... Read More »
Science Applications International Corporation has completed the designs and construction services that will provide NASA with a new vibro-acoustic test capability... Read More »
On November 28, 2011, Accenture and AT&T launched a new medical Imaging system that will enhance the capabilities of healthcare providers. The imaging system will ... Read More »
Brystol-Myers Squibb and AstraZeneca announced yesterday their drug, ONGLYZA®, has been approved for use in Europe as a combination therapy for type two diabetes. ... Read More »